Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, today announced a new contract valued at up to £617,000 with a top-five pharmaceutical company.
To continue reading click here
Top-five pharmaceutical company expands partnership with Aptamer for multi-target Optimer® development program
